quinoxalines has been researched along with chloroquine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Azas, N; Broggi, J; Cohen, A; Dallemagne, P; Hutter, S; Kieffer, C; Laget, M; Lancelot, JC; Lesnard, A; Primas, N; Rathelot, P; Rault, S; Suzanne, P; Vanelle, P; Verhaeghe, P | 1 |
| Igarashi, SJ; Nakano, NI | 1 |
| Gupta, CN; Parimoo, P; Prasad, AL; Rangisetty, JB; Sridhar, N; Srinivas, P; Veeranjaneyulu, A | 1 |
| Akoachere, MB; Andricopulo, AD; Arscott, LD; Becker, K; Davioud-Charvet, E; Kenyon, GL; Krogh, R; McLeish, MJ; Nickel, C; Williams, CH | 1 |
| Hu, C; Lee, H; Solomon, VR; Ulibarri, G | 1 |
| Davis, DP; De Mazière, A; Degtyarev, M; Friedman, LS; Gray, DC; Hoeflich, KP; Klumperman, J; Lee, BB; Lin, J; Lin, K; Murray, LJ; Orr, C; Prior, WW; Stern, HM; Tien, JY; van Dijk, S; Wu, H | 1 |
| Bertrand, M; Correa, RJ; DiMattia, GE; Fazio, EN; McGee, J; Peart, TM; Préfontaine, M; Shepherd, TG; Sugimoto, A; Valdes, YR | 1 |
| Brizuela, M; Burgio, G; Foote, SJ; Huang, HM; McMorran, BJ; Smith, C | 1 |
| Agnamey, P; Azas, N; Bentzinger, G; Cohen, A; Dassonville-Klimpt, A; Guillon, J; Hutter, S; Jonet, A; Moreau, S; Mullie, C; Savrimoutou, S; Schneider, J; Sonnet, P; Taudon, N | 1 |
| Aldana, I; Beltrán-Hortelano, I; Bonilla-Ramirez, L; Bordessoulles, M; Corcuera, L; Franetich, JF; Galiano, S; López de Cerain, A; Mazier, D; Pabón, A; Quiliano, M; Ramirez-Calderon, G; Rios, A; Vettorazzi, A | 1 |
| Funahashi, H; Haruta-Tsukamoto, A; Ishida, Y; Miyahara, Y; Nishimori, T | 1 |
11 other study(ies) available for quinoxalines and chloroquine
| Article | Year |
|---|---|
Synthesis and in vitro evaluation of 4-trichloromethylpyrrolo[1,2-a]quinoxalines as new antiplasmodial agents.
Topics: Antimalarials; Chemistry Techniques, Synthetic; Hep G2 Cells; Humans; Methylation; Plasmodium falciparum; Quinoxalines | 2014 |
Molecular interactions of pyrimidines, purines, and some other heteroaromatic compounds in aqueous media.
Topics: Adenine; Caffeine; Chemical Phenomena; Chemistry; Chloroquine; Drug Stability; Guanidines; Hypoxanthines; Nucleosides; Purines; Pyrimidines; Quinoxalines; Solubility; Theophylline; Tritium; Water | 1970 |
Synthesis of new arylaminoquinoxalines and their antimalarial activity in mice.
Topics: Animals; Antimalarials; Chloroquine; Indicators and Reagents; Malaria; Mannich Bases; Mice; Plasmodium yoelii; Quinoxalines | 2001 |
Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents.
Topics: Animals; Antimalarials; Chloroquine; Dose-Response Relationship, Drug; Drug Resistance; Humans; Inhibitory Concentration 50; Kinetics; Molecular Structure; Oxidation-Reduction; Plasmodium falciparum; Quinoxalines; Thioredoxin-Disulfide Reductase | 2006 |
The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Line, Tumor; Cell Proliferation; Chloroquine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Molecular Structure; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinoxalines; Stereoisomerism; Structure-Activity Relationship | 2008 |
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.
Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Protein 7; Benzylamines; Cell Cycle; Cell Line, Tumor; Chloroquine; Drug Interactions; Female; Furans; Humans; Lysosomes; Macrolides; Mice; Mice, Nude; Mitochondria; Mutation; Neoplasms; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proton-Translocating ATPases; PTEN Phosphohydrolase; Pyridines; Pyrimidines; Quinoxalines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays | 2008 |
Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.
Topics: Allosteric Regulation; Antineoplastic Agents; Ascites; Autophagy; Benzylamines; Cell Line, Tumor; Cell Survival; Chloroquine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Ovarian Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Quinoxalines; Spheroids, Cellular | 2014 |
Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine.
Topics: Animals; Antimalarials; Apoptosis; Cells, Cultured; Chloroquine; Cysteine; Erythrocytes; Homeodomain Proteins; Humans; Immunoblotting; Malaria, Falciparum; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinoxalines | 2014 |
Synthesis and Antimalarial Activity of New Enantiopure Aminoalcoholpyrrolo[ 1,2-a]quinoxalines.
Topics: Amino Alcohols; Animals; Antimalarials; Cell Line, Tumor; Chloroquine; CHO Cells; Cricetulus; Humans; Mefloquine; Plasmodium falciparum; Pyrroles; Quinoxalines; Stereoisomerism | 2018 |
Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
Topics: Animals; Antimalarials; Chloroquine; Female; Hep G2 Cells; Humans; Life Cycle Stages; Malaria; Mice, Inbred BALB C; Plasmodium; Primaquine; Quinoxalines | 2018 |
Perampanel attenuates scratching behavior induced by acute or chronic pruritus in mice.
Topics: Animals; Behavior, Animal; Chloroquine; Cyclopropanes; Disease Models, Animal; Histamine; Hypodermoclysis; Injections, Spinal; Male; Mice; Mice, Inbred C57BL; Nitriles; Pruritus; Pyridones; Quinoxalines; Receptors, AMPA | 2020 |